Glucocorticoid-mediated repression of cytokine gene transcription in human arteritis-SCID chimeras.
暂无分享,去创建一个
C. Kaltschmidt | H. Rittner | A. Brack | C. Weyand | J. Goronzy | B. Younge | C. Weyand | Alexander Brack | Christian Kaltschmidt
[1] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[2] H. Gresham,et al. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice , 1994, The Journal of experimental medicine.
[3] S. Wahl,et al. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[4] S. Abramson,et al. Nitric Oxide: A Novel Mediator of Inflammation , 1995, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[5] U. Oppitz,et al. Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes , 1994, The Journal of experimental medicine.
[6] C. Weyand,et al. Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. , 1996, The American journal of pathology.
[7] G. Hunder,et al. Tissue Cytokine Patterns in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis , 1994, Annals of Internal Medicine.
[8] S. Wahl,et al. Rapid onset synovial inflammation and hyperplasia induced by transforming growth factor beta , 1990, The Journal of experimental medicine.
[9] S. Reed,et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.
[10] L M Wakefield,et al. Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Jimenez,et al. Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes. , 1991, The Journal of clinical investigation.
[12] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[13] D. Boumpas,et al. Glucocorticoid Therapy for Immune-Mediated Diseases: Basic and Clinical Correlates , 1993, Annals of Internal Medicine.
[14] S. Najjar,et al. Negative transcriptional regulation of human interleukin 2 (IL-2) gene by glucocorticoids through interference with nuclear transcription factors AP-1 and NF-AT. , 1993, The Journal of clinical investigation.
[15] C. Weyand,et al. Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. , 1996, The Journal of clinical investigation.
[16] P. Baeuerle,et al. Selective recognition of the activated form of transcription factor NF-kappa B by a monoclonal antibody. , 1995, Biological chemistry Hoppe-Seyler.
[17] T. Kishimoto,et al. Interleukin-6 in autoimmune disorders. , 1992, Seminars in immunology.
[18] S. Wahl,et al. Transforming growth factor beta: the good, the bad, and the ugly , 1994, The Journal of experimental medicine.
[19] A. Brack,et al. Disease patterns and tissue cytokine profiles in giant cell arteritis. , 1997, Arthritis and rheumatism.
[20] M. Karin,et al. Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. , 1995, Science.
[21] D. Männel,et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.
[22] S. Kliewer,et al. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor , 1990, Cell.
[23] G. Hunder,et al. Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis. , 1993, Arthritis and rheumatism.
[24] S. Wahl,et al. Reversal of acute and chronic synovial inflammation by anti- transforming growth factor beta , 1993, The Journal of experimental medicine.
[25] S. Wahl,et al. Suppression of arthritis by an inhibitor of nitric oxide synthase , 1993, The Journal of experimental medicine.
[26] Stephan Gebel,et al. Antitumor promotion and antiinflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone , 1990, Cell.
[27] G. Hunder,et al. Temporal arteritis: a 25-year epidemiologic, clinical, and pathologic study. , 1978, Annals of internal medicine.
[28] P. Baeuerle. Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB Activation in Intact Cells By galf Schreck, Beate Meier,* Daniela N. M~innel,~ Wulf Dr6ge,~ , 1992 .
[29] J. Goronzy,et al. Functional profile of tissue-infiltrating and circulating CD68+ cells in giant cell arteritis. Evidence for two components of the disease. , 1994, The Journal of clinical investigation.
[30] T. Lüscher,et al. Local regulation of the coronary circulation in health and disease: role of nitric oxide and endothelin. , 1995, European heart journal.
[31] S. Jimenez,et al. Differential regulation of transforming growth factor beta-1 gene expression by glucocorticoids in human T and glial cells. , 1995, Journal of immunology.
[32] A. Baldwin,et al. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.